Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/33988
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOLIVEIRA, Arthur M. de
dc.contributor.authorV, Matheus Paulin
dc.contributor.authorVIEIRA, Ana R. E.
dc.contributor.authorMCKINNEY, Alexander M.
dc.contributor.authorROCHA, Antonio da
dc.contributor.authorSANTOS, Germana T. dos
dc.contributor.authorLEITE, Claudia da Costa
dc.contributor.authorGODOY, Luis E. de Souza
dc.contributor.authorLUCATO, Leandro T.
dc.date.accessioned2019-11-06T18:46:42Z-
dc.date.available2019-11-06T18:46:42Z-
dc.date.issued2019
dc.identifier.citationRADIOGRAPHICS, v.39, n.6, Special Issue, p.1672-1695, 2019
dc.identifier.issn0271-5333
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/33988-
dc.description.abstractToxic and metabolic brain disorders are relatively uncommon diseases that affect the central nervous system, but they are important to recognize as they can lead to catastrophic outcomes if not rapidly and properly managed. Imaging plays a key role in determining the most probable diagnosis, pointing to the next steps of investigation, and providing prognostic information. The majority of cases demonstrate bilateral and symmetric involvement of structures at imaging, affecting the deep gray nuclei, cortical gray matter, and/or periventricular white matter, and some cases show specific imaging manifestations. When an appropriate clinical situation suggests exogenous or endogenous toxic effects, the associated imaging pattern usually indicates a restricted group of diagnostic possibilities. Nonetheless, toxic and metabolic brain disorders in the literature are usually approached in the literature by starting with common causal agents and then reaching imaging abnormalities, frequently mixing many different possible manifestations. Conversely, this article proposes a systematic approach to address this group of diseases based on the most important imaging patterns encountered in clinical practice. Each pattern is suggestive of a most likely differential diagnosis, which more closely resembles real-world scenarios faced by radiologists. Basic pathophysiologic concepts regarding cerebral edemas and their relation to imaging are introduced-an important topic for overall understanding. The most important imaging patterns are presented, and the main differential diagnosis for each pattern is discussed. (C) RSNA, 2019eng
dc.language.isoeng
dc.publisherRADIOLOGICAL SOC NORTH AMERICAeng
dc.relation.ispartofRadiographics
dc.rightsrestrictedAccesseng
dc.subject.otherreversible encephalopathy syndromeeng
dc.subject.othermarchiafava-bignami-diseaseeng
dc.subject.otherhepatic-encephalopathyeng
dc.subject.othermagnetic-resonanceeng
dc.subject.othertoluene abuseeng
dc.subject.othermr findingseng
dc.subject.otherdiffusioneng
dc.subject.otherleukoencephalopathyeng
dc.subject.otherlesionseng
dc.subject.otherabnormalitieseng
dc.titleImaging Patterns of Toxic and Metabolic Brain Disorderseng
dc.typearticleeng
dc.rights.holderCopyright RADIOLOGICAL SOC NORTH AMERICAeng
dc.identifier.doi10.1148/rg.2019190016
dc.identifier.pmid31589567
dc.subject.wosRadiology, Nuclear Medicine & Medical Imagingeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalVIEIRA, Ana R. E.:Hosp Sirio Libanes, Dept Radiol, Neuroradiol Sect, Sao Paulo, Brazil
hcfmusp.author.externalMCKINNEY, Alexander M.:Univ Minnesota, Med Ctr, Dept Radiol, Neuroradiol Div, Minneapolis, MN 55455 USA
hcfmusp.author.externalROCHA, Antonio da:Santa Casa Sao Paulo Sch Med Sci, Div Neuroradiol, Sao Paulo, Brazil
hcfmusp.description.beginpage1672
hcfmusp.description.endpage1695
hcfmusp.description.issue6
hcfmusp.description.issueSpecial Issue
hcfmusp.description.volume39
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000489110200008
hcfmusp.origem.id2-s2.0-85072968199
hcfmusp.publisher.cityOAK BROOKeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAlleman AM, 2014, SEMIN ULTRASOUND CT, V35, P153, DOI 10.1053/j.sult.2013.09.009eng
hcfmusp.relation.referenceAlonso J, 2014, SEMIN ULTRASOUND CT, V35, P136, DOI 10.1053/j.sult.2013.09.008eng
hcfmusp.relation.referenceAndrade CS, 2010, BRIT J RADIOL, V83, P437, DOI 10.1259/bjr/27226205eng
hcfmusp.relation.referenceArbelaez A, 2003, AM J NEURORADIOL, V24, P1955eng
hcfmusp.relation.referenceAydin K, 2002, AM J NEURORADIOL, V23, P1173eng
hcfmusp.relation.referenceBathla G, 2014, AM J NEURORADIOL, V35, P833, DOI 10.3174/ajnr.A3486eng
hcfmusp.relation.referenceBlanco M, 2006, AM J NEURORADIOL, V27, P452eng
hcfmusp.relation.referenceBriani C, 2013, NUTRIENTS, V5, P4521, DOI 10.3390/nu5114521eng
hcfmusp.relation.referenceCALDEMEYER KS, 1993, AM J ROENTGENOL, V161, P1259, DOI 10.2214/ajr.161.6.8249738eng
hcfmusp.relation.referenceChokshi FH, 2014, SEMIN ULTRASOUND CT, V35, P75, DOI 10.1053/j.sult.2013.09.006eng
hcfmusp.relation.referenceDonnerstag F, 2012, EUR RADIOL, V22, P506, DOI 10.1007/s00330-011-2286-0eng
hcfmusp.relation.referenceEiden C, 2014, J PSYCHOACTIVE DRUGS, V46, P389, DOI 10.1080/02791072.2014.959215eng
hcfmusp.relation.referenceGao B, 2018, J NEUROL NEUROSUR PS, V89, P14, DOI 10.1136/jnnp-2017-316225eng
hcfmusp.relation.referenceGeibprasert S, 2010, AM J NEURORADIOL, V31, P803, DOI 10.3174/ajnr.A1811eng
hcfmusp.relation.referenceGeyer HL, 2005, NEUROLOGY, V64, P1279, DOI 10.1212/01.WNL.0000156835.12492.30eng
hcfmusp.relation.referenceHegde AN, 2011, RADIOGRAPHICS, V31, P5, DOI 10.1148/rg.311105041eng
hcfmusp.relation.referenceHurley RA, 2015, J NEUROPSYCH CLIN N, V27, pA6, DOI 10.1176/appi.neuropsych.270101eng
hcfmusp.relation.referenceHussain SA, 2017, EPILEPSIA, V58, P674, DOI 10.1111/epi.13712eng
hcfmusp.relation.referenceInaba H, 2008, ANN ONCOL, V19, P178, DOI 10.1093/annonc/mdm466eng
hcfmusp.relation.referenceKang EG, 2010, AM J NEURORADIOL, V31, P559, DOI 10.3174/ajnr.A1856eng
hcfmusp.relation.referenceKemanetzoglou E, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0742-1eng
hcfmusp.relation.referenceKeogh CF, 2003, AM J ROENTGENOL, V180, P847, DOI 10.2214/ajr.180.3.1800847eng
hcfmusp.relation.referenceKim DM, 2016, AM J NEURORADIOL, V37, P1604, DOI 10.3174/ajnr.A4776eng
hcfmusp.relation.referenceKim E, 2007, AM J NEURORADIOL, V28, P1652, DOI 10.3174/ajnr.A0655eng
hcfmusp.relation.referenceKim JY, 2011, J KOREAN NEUROSURG S, V50, P304, DOI 10.3340/jkns.2011.50.4.304eng
hcfmusp.relation.referenceKim TE, 2014, SEMIN ULTRASOUND CT, V35, P85, DOI 10.1053/j.sult.2013.09.004eng
hcfmusp.relation.referenceKumar G, 2010, CLIN NEUROL NEUROSUR, V112, P805, DOI 10.1016/j.clineuro.2010.06.006eng
hcfmusp.relation.referenceKuriyama A, 2011, CLIN NEUROPHARMACOL, V34, P241, DOI 10.1097/WNF.0b013e3182334b35eng
hcfmusp.relation.referenceLai PH, 1996, AM J NEURORADIOL, V17, P1057eng
hcfmusp.relation.referenceLin D, 2017, EMERG RADIOL, V24, P599, DOI 10.1007/s10140-017-1516-4eng
hcfmusp.relation.referenceLIPTON SA, 1994, NEW ENGL J MED, V330, P613eng
hcfmusp.relation.referenceLo CP, 2007, AM J ROENTGENOL, V189, pW205, DOI 10.2214/AJR.07.2425eng
hcfmusp.relation.referenceLucia P, 1996, LANCET, V348, P1450, DOI 10.1016/S0140-6736(04)70094-Xeng
hcfmusp.relation.referenceRamia JM, 2016, CIR ESPAN, V94, P52, DOI 10.1016/j.ciresp.2015.02.009eng
hcfmusp.relation.referenceMatsusue E, 2005, AM J NEURORADIOL, V26, P347eng
hcfmusp.relation.referenceMcKinney AM, 2010, AM J NEURORADIOL, V31, P1471, DOI 10.3174/ajnr.A2112eng
hcfmusp.relation.referenceMcKinney AM, 2007, AM J ROENTGENOL, V189, P904, DOI 10.2214/AJR.07.2024eng
hcfmusp.relation.referenceMcKinney AM, 2009, AM J ROENTGENOL, V193, P192, DOI 10.2214/AJR.08.1176eng
hcfmusp.relation.referenceMorita S, 2003, J NEUROL SCI, V216, P183, DOI 10.1016/S0022-510X(03)00219-3eng
hcfmusp.relation.referenceMoritani T, 2005, AM J NEURORADIOL, V26, P216eng
hcfmusp.relation.referenceMurray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40eng
hcfmusp.relation.referenceNa DG, 2005, RADIOLOGY, V235, P992, DOI 10.1148/radiol.2353040571eng
hcfmusp.relation.referenceOsborn AG, 2017, OSBORNS BRAIN, P905eng
hcfmusp.relation.referenceOzutemiz C, 2019, AM J NEURORADIOL, V40, P267, DOI 10.3174/ajnr.A5947eng
hcfmusp.relation.referencePearl PL, 2009, EPILEPSIA, V50, P184, DOI 10.1111/j.1528-1167.2008.01728.xeng
hcfmusp.relation.referencePeter P, 2014, SINGAP MED J, V55, pE17eng
hcfmusp.relation.referencePiciucchi S, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.102053eng
hcfmusp.relation.referenceRamadan S, 2013, NMR BIOMED, V26, P1630, DOI 10.1002/nbm.3045eng
hcfmusp.relation.referenceReddick WE, 2005, AM J NEURORADIOL, V26, P1263eng
hcfmusp.relation.referenceRimkus CD, 2014, SEMIN ULTRASOUND CT, V35, P97, DOI 10.1053/j.sult.2013.09.005eng
hcfmusp.relation.referenceRovira A, 2008, AM J NEURORADIOL, V29, P1612, DOI 10.3174/ajnr.A1139eng
hcfmusp.relation.referenceRykken JB, 2014, SEMIN ULTRASOUND CT, V35, P118, DOI 10.1053/j.sult.2013.09.007eng
hcfmusp.relation.referenceSchaefer PW, 1997, STROKE, V28, P1082, DOI 10.1161/01.STR.28.5.1082eng
hcfmusp.relation.referenceSener RN, 2003, AM J NEURORADIOL, V24, P1475eng
hcfmusp.relation.referenceShoback DM, 2016, J CLIN ENDOCR METAB, V101, P2300, DOI 10.1210/jc.2015-3909eng
hcfmusp.relation.referenceStarkey J, 2017, RADIOGRAPHICS, V37, P562, DOI 10.1148/rg.2017160085eng
hcfmusp.relation.referenceStone JB, 2016, NAT REV CLIN ONCOL, V13, P92, DOI 10.1038/nrclinonc.2015.152eng
hcfmusp.relation.referenceTamrazi B, 2012, RADIOGRAPHICS, V32, P701, DOI 10.1148/rg.323115115eng
hcfmusp.relation.referenceTatewaki Y, 2012, BRIT J RADIOL, V85, pE87, DOI 10.1259/bjr/26842276eng
hcfmusp.relation.referenceTung CS, 2010, AM J NEURORADIOL, V31, P1506, DOI 10.3174/ajnr.A1897eng
hcfmusp.relation.referenceU-King-Im JM, 2011, AM J NEURORADIOL, V32, P413, DOI 10.3174/ajnr.A2290eng
hcfmusp.relation.referenceVALK J, 1992, AM J NEURORADIOL, V13, P747eng
hcfmusp.relation.referenceVaneckova M, 2015, NEUROENDOCRINOL LETT, V36, P737eng
hcfmusp.relation.referenceWong DST, 2013, AM J NEURORADIOL, V34, P1456, DOI 10.3174/ajnr.A3423eng
hcfmusp.relation.referenceYan RF, 2013, EXP THER MED, V6, P71, DOI 10.3892/etm.2013.1077eng
dc.description.indexMEDLINEeng
hcfmusp.citation.scopus48-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - HC/InRad
Instituto de Radiologia - HC/InRad

Artigos e Materiais de Revistas Científicas - HC/IPq
Instituto de Psiquiatria - HC/IPq

Artigos e Materiais de Revistas Científicas - LIM/44
LIM/44 - Laboratório de Ressonância Magnética em Neurorradiologia


Files in This Item:
File Description SizeFormat 
art_OLIVEIRA_Imaging_Patterns_of_Toxic_and_Metabolic_Brain_Disorders_2019.PDF
  Restricted Access
publishedVersion (English)3.78 MBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.